HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bruce Ovbiagele Selected Research

Tissue Plasminogen Activator (Alteplase)

11/2014Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.
11/2013Sex differences in revascularization interventions after acute ischemic stroke.
10/2013Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
1/2013Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100.
8/2011Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.
1/2011Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review.
11/2010Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts.
4/2010Therapeutic hypothermia for acute ischemic stroke.
12/2003Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke.
9/2003Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bruce Ovbiagele Research Topics

Disease

192Stroke (Strokes)
06/2022 - 09/2003
82Ischemic Stroke
06/2022 - 01/2003
29Hypertension (High Blood Pressure)
01/2022 - 09/2005
21Transient Ischemic Attack
06/2022 - 12/2004
11Atrial Fibrillation
01/2021 - 01/2006
11Cardiovascular Diseases (Cardiovascular Disease)
08/2019 - 01/2009
11Brain Ischemia (Cerebral Ischemia)
03/2018 - 01/2005
10Hemorrhage
06/2022 - 06/2010
10Diabetes Mellitus
12/2020 - 05/2007
10Infarction (Infarctions)
06/2012 - 09/2007
9Myocardial Infarction
02/2017 - 01/2011
8Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2022 - 12/2012
8Heart Failure
01/2021 - 11/2010
7Atherosclerosis
01/2022 - 01/2008
7Hemorrhagic Stroke
01/2022 - 10/2010
7Cerebral Hemorrhage
12/2019 - 01/2009
6Thrombosis (Thrombus)
11/2020 - 11/2003
6Coronary Disease (Coronary Heart Disease)
01/2019 - 11/2010
5Ischemia
11/2010 - 01/2003
5Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2010 - 12/2004
4Hyperlipidemias (Hyperlipidemia)
01/2020 - 01/2009
4Vascular Diseases (Vascular Disease)
02/2016 - 01/2006
3Type 2 Diabetes Mellitus (MODY)
07/2022 - 01/2017
3Heart Diseases (Heart Disease)
01/2021 - 03/2007
3Epilepsy (Aura)
02/2020 - 09/2017
3Obesity
01/2020 - 05/2017
3Hematoma
12/2019 - 02/2012
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
08/2019 - 12/2010
3Pathologic Constriction (Stenosis)
09/2018 - 06/2008
3Embolic Stroke
02/2017 - 01/2014
3Insulin Resistance
01/2017 - 01/2008
3Albuminuria
01/2013 - 08/2008
3Dyslipidemias (Dyslipidemia)
08/2011 - 07/2006
3Hypothermia
04/2010 - 09/2003
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2009 - 07/2008
2Patent Foramen Ovale
01/2022 - 01/2011
2Status Epilepticus (Complex Partial Status Epilepticus)
10/2021 - 01/2021
2Seizures (Absence Seizure)
02/2020 - 01/2019
2Body Weight (Weight, Body)
01/2020 - 01/2019
2Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 05/2007

Drug/Important Bio-Agent (IBA)

24Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 01/2005
23Antihypertensive Agents (Antihypertensives)IBA
05/2021 - 09/2005
16Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2022 - 11/2006
12LipidsIBA
12/2020 - 01/2005
12CholesterolIBA
01/2020 - 01/2005
11AnticoagulantsIBA
01/2022 - 02/2006
10Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2021 - 01/2008
10HomocysteineIBA
02/2016 - 07/2008
10Tissue Plasminogen Activator (Alteplase)FDA Link
11/2014 - 09/2003
9Glucose (Dextrose)FDA LinkGeneric
07/2022 - 05/2007
9VitaminsIBA
05/2017 - 01/2010
7CreatinineIBA
01/2015 - 05/2007
6Clopidogrel (Plavix)FDA Link
06/2022 - 10/2013
6oxidized low density lipoproteinIBA
01/2022 - 07/2006
6Warfarin (Coumadin)FDA LinkGeneric
12/2018 - 06/2008
6Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2018 - 01/2018
6Biomarkers (Surrogate Marker)IBA
03/2018 - 12/2008
6Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2018 - 07/2008
6Pharmaceutical PreparationsIBA
04/2016 - 01/2003
5Triglycerides (Triacylglycerol)IBA
01/2020 - 10/2009
5Pioglitazone (Actos)FDA Link
01/2019 - 01/2017
4SaltsIBA
01/2022 - 02/2017
4LDL CholesterolIBA
01/2022 - 11/2014
4Biological ProductsIBA
06/2018 - 07/2011
4Vitamin B Complex (B Vitamins)IBA
02/2016 - 07/2013
4HDL CholesterolIBA
11/2014 - 09/2006
4AlbuminsIBA
01/2013 - 09/2003
3DabigatranFDA Link
12/2020 - 07/2017
3RivaroxabanIBA
12/2020 - 07/2017
3Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2020 - 01/2015
3edoxabanIBA
12/2020 - 07/2017
3apixabanIBA
12/2020 - 07/2017
3Vitamin KFDA Link
12/2020 - 07/2017
3ORALIT (ORS)IBA
11/2019 - 01/2018
3Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2007
3Indicators and Reagents (Reagents)IBA
02/2012 - 11/2003
3Neuroprotective AgentsIBA
12/2003 - 01/2003
2Hypoglycemic Agents (Hypoglycemics)IBA
07/2022 - 03/2017
2Blood Glucose (Blood Sugar)IBA
12/2020 - 01/2019
2LDL Lipoproteins (beta Lipoproteins)IBA
02/2020 - 02/2010
2Dihydrotachysterol (AT 10)IBA
05/2019 - 01/2018
2N(4)-oleylcytosine arabinosideIBA
12/2018 - 07/2017

Therapy/Procedure

92Therapeutics
07/2022 - 01/2003
17Secondary Prevention
12/2020 - 12/2004
8Thrombectomy
03/2022 - 12/2010
5Telerehabilitation
09/2018 - 09/2017
4Highly Active Antiretroviral Therapy (HAART)
11/2021 - 02/2011
4Patient Readmission
01/2021 - 01/2019
4Thrombolytic Therapy
11/2014 - 09/2005
3Precision Medicine
06/2022 - 01/2020
3Drug Therapy (Chemotherapy)
01/2022 - 01/2006
3Length of Stay
10/2021 - 09/2006
3Physical Therapy Modalities (Physical Therapy Technique)
01/2018 - 10/2017
3Endovascular Procedures
10/2015 - 01/2009
3Continuity of Patient Care
07/2011 - 01/2006
3Catheters
10/2009 - 11/2003
2Glycemic Control
07/2022 - 12/2010
2Ambulatory Care (Outpatient Care)
01/2022 - 12/2020
2Stroke Rehabilitation
09/2018 - 03/2015
2Punctures
09/2018 - 03/2018